Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-001670

Chief Patient Supply Officer sold 1,070 shares at $4.06 ($4,349)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lunger John Chief Patient Supply Officer 2022-01-04 Sale −1,070 $4.06 $4,349 1,755 D
Open-market sales · 1,070 sh · avg $4.06 · $4,349
Loading xslF345X03/tm221700-3_4seq1.xml…